Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher, Gastrointestinal Oncology at Antoni van Leeuwenhoek, shared on LinkedIn:
“Humbled and happy to announce that I’ve been selected as a shortlisted finalist in oncology for the 2026 Takeda Innovators in Science Award with Nature Portfolio.
This award celebrates groundbreaking research by early career scientists who are advancing the frontiers of scientific discovery in the areas of gastrointestinal and inflammatory diseases, neuroscience, and oncology.
Extremely honored to receive this recognition and excited about Nature’s career development programs and connection with fellow nominees. Fantastic opportunity, all with the goal to expand my research aimed at further improving immunotherapy responses and patient outcomes through innovative clinical trials and translational research.
More posts from Myriam Chalabi on OncoDaily.